| LDR | | 01495nmm uu200373 4500 |
| 001 | | 000000333586 |
| 005 | | 20240805173320 |
| 008 | | 181129s2018 |||||||||||||||||c||eng d |
| 020 | |
▼a 9780438132702 |
| 035 | |
▼a (MiAaPQ)AAI10750362 |
| 035 | |
▼a (MiAaPQ)medicine.yale:10703 |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 248032 |
| 082 | 0 |
▼a 610 |
| 100 | 1 |
▼a Cyrenne, Benoit M. |
| 245 | 10 |
▼a Synergy of BCL2 and Histone Deacetylase Inhibition against Leukemic Cells from Cutaneous T-cell Lymphoma Patients. |
| 260 | |
▼a [S.l.] :
▼b Yale University.,
▼c 2018 |
| 260 | 1 |
▼a Ann Arbor :
▼b ProQuest Dissertations & Theses,
▼c 2018 |
| 300 | |
▼a 73 p. |
| 500 | |
▼a Source: Dissertation Abstracts International, Volume: 79-11(E), Section: B. |
| 500 | |
▼a Adviser: Michael Girardi. |
| 502 | 1 |
▼a Thesis (M.D.)--Yale University, 2018. |
| 520 | |
▼a The presence and degree of peripheral blood involvement in patients with cutaneous T-cell lymphoma (CTCL) portend a worse clinical outcome. Available systemic therapies for CTCL may variably decrease tumor burden and improve quality of life, but |
| 590 | |
▼a School code: 0265. |
| 650 | 4 |
▼a Medicine. |
| 690 | |
▼a 0564 |
| 710 | 20 |
▼a Yale University.
▼b Yale School of Medicine. |
| 773 | 0 |
▼t Dissertation Abstracts International
▼g 79-11B(E). |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 0265 |
| 791 | |
▼a M.D. |
| 792 | |
▼a 2018 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T14997100
▼n KERIS |
| 980 | |
▼a 201812
▼f 2019 |
| 990 | |
▼a 관리자 |